Centinel Spine Gains FDA Approval for Additional prodisc Devices

Centinel Spine announced FDA premarket application (PMA) approval for 1-level indications for three additional cervical total disc replacement (TDR) devices: prodisc C Vivo, prodisc C Nova and prodisc C SK. These join the currently available prodisc C implant, widely used throughout the U.S.

prodisc C Vivo and prodisc C Nova products have been...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us